246 related articles for article (PubMed ID: 11642602)
1. Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines.
Czerniecki BJ; Cohen PA; Faries M; Xu S; Roros JG; Bedrosian I
Crit Rev Immunol; 2001; 21(1-3):157-78. PubMed ID: 11642602
[TBL] [Abstract][Full Text] [Related]
2. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
3. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
4. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
[TBL] [Abstract][Full Text] [Related]
5. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
[TBL] [Abstract][Full Text] [Related]
6. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.
Kaliński P; Schuitemaker JH; Hilkens CM; Kapsenberg ML
J Immunol; 1998 Sep; 161(6):2804-9. PubMed ID: 9743339
[TBL] [Abstract][Full Text] [Related]
8. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
9. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
10. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
12. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
Sato T; Terai M; Yasuda R; Watanabe R; Berd D; Mastrangelo MJ; Hasumi K
Cancer Immunol Immunother; 2004 Jan; 53(1):53-61. PubMed ID: 13680192
[TBL] [Abstract][Full Text] [Related]
13. Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.
Vegh Z; Mazumder A
Cancer Immunol Immunother; 2003 Feb; 52(2):67-79. PubMed ID: 12594570
[TBL] [Abstract][Full Text] [Related]
14. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development.
Faries MB; Bedrosian I; Xu S; Koski G; Roros JG; Moise MA; Nguyen HQ; Engels FH; Cohen PA; Czerniecki BJ
Blood; 2001 Oct; 98(8):2489-97. PubMed ID: 11588047
[TBL] [Abstract][Full Text] [Related]
15. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.
Liu KJ; Lu LF; Cheng HT; Hung YM; Shiou SR; Whang-Peng J; Juang SH
Cancer Gene Ther; 2004 Feb; 11(2):135-47. PubMed ID: 14647233
[TBL] [Abstract][Full Text] [Related]
16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
17. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation.
Wang YS; Chi KH; Chu RM
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):186-98. PubMed ID: 17617471
[TBL] [Abstract][Full Text] [Related]
19. Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells.
Velten FW; Rambow F; Metharom P; Goerdt S
Mol Immunol; 2007 Mar; 44(7):1544-50. PubMed ID: 17023048
[TBL] [Abstract][Full Text] [Related]
20. Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.
Gustafsson K; Ingelsten M; Bergqvist L; Nyström J; Andersson B; Karlsson-Parra A
Cancer Res; 2008 Jul; 68(14):5965-71. PubMed ID: 18632652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
